AC Immune
ACIU

AC Immune (ACIU) analyst forecast and price target

Analyst forecast

Buy

Consensus of 4 analyst ratings

Buy
4
Hold
0
Sell
0

Recent analyst ratings

FirmActionRatingPrice targetDate
BTIGMaintainedBuy$8.00Sep 23, 2026
BTIGMaintainedBuy$8.00Aug 20, 2026
BTIGMaintainedBuy$8.00Aug 5, 2026
BTIGMaintainedBuy$8.00May 4, 2026
BTIGMaintainedBuy$8.00Mar 16, 2026
BTIGMaintainedBuy$8.00Nov 4, 2025
BTIGMaintainedBuy$8.00Sep 8, 2025
HC Wainwright & Co.MaintainedBuy$12.00 from $16.00May 1, 2025
HC Wainwright & Co.MaintainedBuy$16.00Apr 3, 2025
HC Wainwright & Co.MaintainedBuy$16.00Mar 14, 2025
HC Wainwright & Co.MaintainedBuy$16.00Nov 15, 2024
HC Wainwright & Co.MaintainedBuy$16.00Nov 6, 2024
HC Wainwright & Co.MaintainedBuy$16.00Sep 18, 2024
BTIGInitiated CoverageBuy$8.00May 31, 2024
HC Wainwright & Co.MaintainedBuy$16.00Mar 15, 2024
HC Wainwright & Co.MaintainedBuy$16.00Nov 13, 2023
HC Wainwright & Co.MaintainedBuy$16.00Aug 7, 2023
HC Wainwright & Co.MaintainedBuy$16.00Jun 28, 2023
HC Wainwright & Co.MaintainedBuy$16.00May 1, 2023

Frequently asked questions

  • Is ACIU a buy, sell, or hold?

    Analysts covering AC Immune currently average a Buy rating: 4 buy, 0 hold and 0 sell, from 4 analysts. Ratings reflect analyst opinion, not investment advice.

  • What is the latest analyst rating on ACIU?

    On Sep 23, 2026, BTIG maintained AC Immune at Buy with a price target of $8.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.